Insights

July 2022

Manufacturers

Why FormularyDecisions® is the right choice for enterprise biopharma payer engagement

July 2022

formulary decisions enterprise man working on computer

Manufacturers

Webinar slides: Navigating Reimbursement and Access Challenges for Novel Cell and Gene Therapies

Tasmina Hydery

June 2022

Manufacturers

Differentiate your product with FormularyDecisions®

Tasmina Hydery; Sara Linnerooth

April 2022

Differentiate your product with FormularyDecisions

Manufacturers

Six insights driving the evolution of FormularyDecisions®

March 2022

Manufacturers

Essential skills for outsourced field solutions teams

November 2021

Manufacturers

Building your field reimbursement and access team: The translational experience and skills that matter most

September 2021

Manufacturers

eBook: Bringing innovation to market with digital therapeutics

August 2021

Manufacturers

Navigating the payer landscape for digital therapeutics

Manufacturers

Patient support for digital therapeutics: Do's and don'ts for designing your program

Manufacturers

Work worth doing: Innovative field solutions

Manufacturers

Innomar Strategies: 20 years of innovative market access solutions

Manufacturers

Work worth doing: FormularyDecisions

Laurie Fazio

May 2021

Manufacturers

The essential guide to drug commercialization

Matt Sarnes, PharmD; Brian Ansay

May 2021

Manufacturers

Podcast: ThinkLive Commercialization 2021

May 2021

Manufacturers

On-demand webinar: Accelerating access to therapy (a view from the front lines)

Manufacturers

The hidden value of integrated commercialization services: A manufacturer’s perspective

Manufacturers

Ebook: Strategic partnerships for unlocking product potential

Strategic partnerships for unlocking product potential ebook

Manufacturers

The Value of Real-World Evidence in Canadian Drug Commercialization: Part 2

Manufacturers

How to make the most of integrated commercialization solutions

Corey Ford, MHA; Dale Hanna

March 2021

Manufacturers

Strategies for addressing copay accumulators: What manufacturers need to know

March 2021

Manufacturers

Webinar: uptake or heartbreak with biosimilars? Progress and perspectives

February 2021

Manufacturers

Pre-launch checklist: What to look for in a commercialization partner

February 2021

Manufacturers

Checklist: Four things to look for in a field services partner

February 2021

Manufacturers

Case study: an innovative field reimbursement program expands patient access

January 2021

Manufacturers

Cell and gene therapies: bringing innovation to market

December 2020

Manufacturers

Pharma in the field: Ashley's story

November 2020

Manufacturers

Pharma in the field: Tierra's story

November 2020

Manufacturers

Ebook: Virtual drug commercialization

Mike Sweeney; Kim McLeod, MPH

November 2020

Manufacturers

Is a contact-free clinical trial possible?

World Courier

September 2020

Patient support launch guide: novel therapies

September 2020

Manufacturers

Is your PIE incomplete?

September 2020

Manufacturers

Rethink field services: Three myths keeping access barriers in front of your product

August 2020

Manufacturers

Solving access, reimbursement, and PAP awareness problems

August 2020

Male doctor speaking to patient on a tablet

Manufacturers

Pharma in the field: Sales reps vs. reimbursement and access specialists

Matt Sarnes, PharmD; Allen Lising

July 2020

Manufacturers

The Future of Payer Engagement: How Pharma Can Break Through

June 2020

Manufacturers

The Value of Virtual: How Remote Workshops Can Keep Market Access Efforts Moving

Bre Penzner; Nancy Young

May 2020

Manufacturers

Distant But Engaged: Transitioning to Virtual Training

May 2020

Manufacturers

Mind the (Evidence) Gap

Kim McLeod, MPH

February 2020

Manufacturers

InnomarLive 2019: Commercializing in Canada

Sean McGowan; Rick Lozano

December 2019

Manufacturers

Biosimilars: Market Insights and Growth Factors

September 2019

The growth of biosimilars presents a significant opportunity to reduce the cost of care and provide patients with greater access to affordable treatments. Our experts assess the current state and future of the biosimilars market.

Manufacturers

Biosimilars: Launch Insights From the Field

September 2019

How are biosimilar manufacturers approaching patients, providers and payers? What can they do to differentiate? Xcenda shares insight from our field programs.

Manufacturers

How Digital Innovation Drives Improved Market Access Strategies

July 2019

In this digital age, how can pharmaceutical manufacturers leverage innovative tools to prove their product's value proposition and overcome market access challenges?

Health Systems

Coordinated Care: The Value of Patient and Provider Satisfaction within Health System Specialty Pharmacies

April 2019

Download this new white paper from IHOC - Coordinated Care: The Value of Patient and Provider Satisfaction within Health System Specialty Pharmacies - to learn the key insights about the role HSSPs play in improving the patient experience and why patient and provider satisfaction are important data points for both payers and manufacturers to consider when deciding to include HSSPs in their networks.

Manufacturers

How to Navigate Cell and Gene Therapy Reimbursement: Part Two

Ana Stojanovska

June 2018

An executive Q&A on the role of data and the future of innovative reimbursement modeling for cell and gene therapies.

Manufacturers

How to Navigate Cell and Gene Therapy Reimbursement: Part One

Ana Stojanovska

June 2018

An executive Q&A on challenges and opportunities related to reimbursement, coding and coverage for cell and gene therapies.

Infographic: The Road to Commercialization in Canada

May 2018

Manufacturers

What Do Payers Think About Digital Health Technologies

September 2017

How are payers thinking about apps, wearables and other digital health technologies?

Manufacturers

The Route to Market Access in Canada